Your browser doesn't support javascript.
loading
Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract.
Krabbe, Laura-Maria; Bagrodia, Aditya; Haddad, Ahmed Q; Kapur, Payal; Khalil, Dina; Hynan, Linda S; Wood, Christopher G; Karam, Jose A; Weizer, Alon Z; Raman, Jay D; Remzi, Mesut; Rioux-Leclercq, Nathalie; Haitel, Andrea; Roscigno, Marco; Bolenz, Christian; Bensalah, Karim; Sagalowsky, Arthur I; Shariat, Shahrokh F; Lotan, Yair; Margulis, Vitaly.
Afiliação
  • Krabbe LM; Department of Urology, University of Texas Medical Center, Dallas, Texas; Department of Urology, University of Muenster Medical Center, Muenster, Germany.
  • Bagrodia A; Department of Urology, University of Texas Medical Center, Dallas, Texas.
  • Haddad AQ; Department of Urology, University of Texas Medical Center, Dallas, Texas.
  • Kapur P; Department of Urology, University of Texas Medical Center, Dallas, Texas; Department of Pathology, University of Texas Medical Center, Dallas, Texas.
  • Khalil D; Department of Pathology, University of Texas Medical Center, Dallas, Texas.
  • Hynan LS; Department of Biostatistics, University of Texas Medical Center, Dallas, Texas.
  • Wood CG; Department of Urology, MD Anderson Cancer Center, Houston, Texas.
  • Karam JA; Department of Urology, MD Anderson Cancer Center, Houston, Texas.
  • Weizer AZ; Department of Urology, University of Michigan Cancer Center, Ann Arbor, Michigan.
  • Raman JD; Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
  • Remzi M; Department of Urology, Medical University Vienna, Vienna, Austria.
  • Rioux-Leclercq N; Department of Pathology, Centre Hospitalier Universitaire de Rennes, Rennes, France.
  • Haitel A; Department of Pathology, Medical University Vienna, Vienna, Austria.
  • Roscigno M; Department of Urology, Ospedali Riuniti di Bergamo, Bergamo, Italy.
  • Bolenz C; Department of Urology, Mannheim Medical Center, University of Heidelberg, Mannheim, Germany.
  • Bensalah K; Department of Urology, Centre Hospitalier Universitaire de Rennes, Rennes, France.
  • Sagalowsky AI; Department of Urology, University of Texas Medical Center, Dallas, Texas.
  • Shariat SF; Department of Urology, Medical University Vienna, Vienna, Austria.
  • Lotan Y; Department of Urology, University of Texas Medical Center, Dallas, Texas.
  • Margulis V; Department of Urology, University of Texas Medical Center, Dallas, Texas. Electronic address: Vitaly.margulis@utsouthwestern.edu.
J Urol ; 193(5): 1486-93, 2015 May.
Article em En | MEDLINE | ID: mdl-25451830
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ureterais / Carcinoma de Células de Transição / Antígeno Ki-67 / Neoplasias Renais / Pelve Renal Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Urol Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ureterais / Carcinoma de Células de Transição / Antígeno Ki-67 / Neoplasias Renais / Pelve Renal Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Urol Ano de publicação: 2015 Tipo de documento: Article